Literature DB >> 11083534

Current practice of radioiodine treatment in the management of differentiated thyroid cancer in Germany.

S Hoelzer1, D Steiner, R Bauer, C Reiners, J Farahati, S A Hundahl, J Dudeck.   

Abstract

This prospective, observational study of a cohort of thyroid cancer patients in Germany focusses on the "real-world" practice in the management of thyroid cancer patients. This report includes data from 2376 patients with primary differentiated thyroid carcinoma first diagnosed in the year 1996. The study reveals considerable differences in actual practice concerning surgery and radioiodine treatment. The results indicate that consensus is lacking with respect to the multimodality treatment approach for differentiated thyroid carcinoma. Our analysis represents the most current and comprehensive national assessment of presenting patient characteristics, diagnostic tests, treatment and complications for thyroid cancer.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083534     DOI： 10.1007/s002590000333

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  5 in total

1.  Looking under the hood of "the Cadillac of cancers:" radioactive iodine-related craniofacial side effects among patients with thyroid cancer.

Authors:  Samantha A Diamond-Rossi; Jacqueline Jonklaas; Roxanne E Jensen; Charlene Kuo; Selma Stearns; Giuseppe Esposito; Bruce J Davidson; George Luta; Gary Bloom; Kristi D Graves
Journal:  J Cancer Surviv       Date:  2020-06-06       Impact factor: 4.442

2.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.

Authors:  Shin Young Jeong; Hae Won Kim; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

Review 3.  RETRACTED ARTICLE: Radiation sialadenitis induced by high-dose radioactive iodine therapy.

Authors:  Shin Young Jeong; Jaetae Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-04-21

4.  A Functional Scoring System Based on Salivary Gland Scintigraphy for Evaluating Salivary Gland Dysfunction Secondary to 131I therapy in Patients with Differentiated Thyroid Carcinoma.

Authors:  Yasuhiro Maruoka; Shingo Baba; Takuro Isoda; Yoshiyuki Kitamura; Koichiro Abe; Masayuki Sasaki; Hiroshi Honda
Journal:  J Clin Diagn Res       Date:  2017-08-01

5.  QPRT: a potential marker for follicular thyroid carcinoma including minimal invasive variant; a gene expression, RNA and immunohistochemical study.

Authors:  Nora Hinsch; Matthias Frank; Claudia Döring; Christian Vorländer; Martin-Leo Hansmann
Journal:  BMC Cancer       Date:  2009-03-26       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.